RedHill seeks Ebola treatment role for opaganib as cases top 3,200
Go back to RedHill seeks Ebola treatment role for opaganib as cases top 3,200| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.65 -0.07 (9.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $16.54 | |||
| Open | $0.72 | 52 Week Low | $8.10 | |||
| Day High | $0.73 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $0.00 | |||
| Volume | 404,926 | |||||
